![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Shares of Allergan, Inc. (AGN) hit a 52-week high of $109.74 almost at the end of the trading session on Mar 4, 2013. The stock was buoyed by the announcement that it was a step closer to...
Allergan, Inc. (AGN) recently announced that the tender offer to purchase the shares of MAP Pharmaceuticals, Inc. (MAPP) and withdrawal rights have expired on Feb 28, 2013. We note that Allergan...
Allergan, Inc. (NYSE: AGN) (“Allergan”) today announced the expiration of the tender offer (the “Offer”) initiated by its wholly-owned subsidiary, Groundhog Acquisition, Inc...
Allergan, Inc. (NYSE: AGN) (“Allergan”) and MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) (“MAP”) today announced that the Federal Trade Commission has granted early termination of the waiting...
Botox sales of about $475 million, the most ever, help boost earnings 16% --Expenses to rise in 2013 on increased R&D spending, U.S. health-care costs --Allergan continues expansion beyond...
Allergan, Inc. (AGN) reported fourth quarter 2012 earnings of $1.15 per share, missing the Zacks Consensus Estimate of $1.19 per share. While earnings increased 15.0% from the year-ago...
By Tess Stynes Allergan Inc.'s (AGN) fourth-quarter earnings rose 16% as the botox-maker reported growing revenue and fewer one-time charges. For the year, the company projected per-share earnings...
NEW YORK, Feb. 1, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of MAP Pharmaceuticals Inc. ("MAP" or the "Company") (Nasdaq:MAPP) of claims of breaches of fiduciary duty and other...
Allergan, Inc. (AGN) recently announced that it has commenced a cash tender offer to purchase all the shares of MAP Pharmaceuticals, Inc. (MAPP) for $25.00 per share. Allergan had announced...
Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug Pharmaceutical Company Achieves Positive In-Vitro Testing Results Diabetes Drug Global Pharmaceutical &...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.1 | -2.95698924731 | 37.2 | 37.4 | 35.799999 | 746 | 36.40147526 | DE |
4 | 0.4 | 1.12044817927 | 35.7 | 37.6 | 33.799999 | 2516 | 36.46173349 | DE |
12 | 0.9 | 2.55681818182 | 35.2 | 37.6 | 33.2 | 1749 | 35.94208429 | DE |
26 | 6.15 | 20.5342237062 | 29.95 | 37.6 | 28.15 | 1860 | 34.15296778 | DE |
52 | 3.2 | 9.726443769 | 32.9 | 37.6 | 28.15 | 1314 | 33.34014608 | DE |
156 | -5.4 | -13.0120481928 | 41.5 | 44.55 | 24.65 | 5869 | 32.50053068 | DE |
260 | 16.822 | 87.2600892209 | 19.278 | 46.5 | 17.52 | 11419 | 33.69059451 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions